Close

Sucampo Pharma (SCMP) Deal Terms 'Substantially Undervalues' Company, Worth $29/Share At Least - Nomura/Instinet

December 26, 2017 1:41 PM EST Send to a Friend
Nomura/Instinet maintains Buy on Sucampo Pharmaceuticals (NASDAQ: SCMP) price target of $43.00.Analyst Chris Marai comments "We believe that the transaction ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login